Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing

Abstract

BackgroundSingle-cell micro-metastases of solid tumors often occur in the bone marrow. These disseminated tumor cells (DTCs) may resist therapy and lay dormant or progress to cause overt bone and visceral metastases. The molecular nature of DTCs remains elusive, as well as when and from where in the tumor they originate. Here, we apply single-cell sequencing to identify and trace the origin of DTCs in breast cancer.ResultsWe sequence the genomes of 63 single cells isolated from six non-metastatic breast cancer patients. By comparing the cells’ DNA copy number aberration (CNA) landscapes with those of the primary tumors and lymph node metastasis, we establish that 53% of the single cells morphologically classified as tumor cells are DTCs disseminating from the observed tumor. The remaining cells represent either non-aberrant “normal” cells or “aberrant cells of unknown origin” that have CNA landscapes discordant from the tumor. Further analyses suggest that the prevalence of aberrant cells of unknown origin is age-dependent and that at least a subset is hematopoietic in origin. Evolutionary reconstruction analysis of bulk tumor and DTC genomes enables ordering of CNA events in molecular pseudo-time and traced the origin of the DTCs to either the main tumor clone, primary tumor subclones, or subclones in an axillary lymph node metastasis.ConclusionsSingle-cell sequencing of bone marrow epithelial-like cells, in parallel with intra-tumor genetic heterogeneity profiling from bulk DNA, is a powerful approach to identify and study DTCs, yielding insight into metastatic processes. A heterogeneous population of CNA-positive cells is present in the bone marrow of non-metastatic breast cancer patients, only part of which are derived from the observed tumor lineages.Electronic supplementary materialThe online version of this article (doi:10.1186/s13059-016-1109-7) contains supplementary material, which is available to authorized users.

Genomic Evolution of Breast Cancer Metastasis and Relapse

“…In particular, the vast majority of driver mutations found in the primary cancer would also be present in the relapsing clone. Our observation of late dissemination is consistent with the findings of a recent study that combined bulk sequencing of primary tumors with single-cell sequencing of bone marrow-derived disseminated tumor cells, the presumed precursor of clinically overt metastatic disease ( Demeulemeester et al., 2016 ). Although the genome of a metastatic clone may be similar to the primary tumor at first diagnosis, by the time it has expanded to be clinically detectable, extensive further genomic changes have occurred.…”

A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer

“…All three different methods employ the detection of cytokeratins as marker of epithelial cells. However, it should be mentioned here that the immunocytochemical staining of bone marrow aspirates for a broad spectrum of cytokeratins in patients with breast cancer, showed that the true positive rate for the detection of disseminated tumor cells was 52.6±11.5% [29]. …”

Circulating Tumor Cells in Diagnosis and Treatment of Lung Cancer

“…Nowadays, single-cell genotyping has become a very popular method, allowing determination of cancer "phylogenesis" and evolution. Demeulemeester et al have constructed cancer "phylogenetic" trees using singlecell sequencing (52).…”